단백질 결합 분석 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 제품 및 서비스별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Ultrafiltration, Ultracentrifugation), By Product & Services (Instrument), By End Use (CROs), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,530,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,964,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,831,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

단백질 결합 분석 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 단백질 결합 분석 시장 규모는 2024년부터 2030년까지 연평균 10.2%의 CAGR로 2030년까지 8억 9,630만 달러에 달할 것으로 예상됩니다.

단백질 결합 분석은 신약 개발 프로그램의 전임상 단계에서 점점 더 많이 사용되고 있습니다. 이러한 분석은 표적 분자를 검출하는 데 도움이 되며, 치료제와 생물학적 제제의 특성에 대한 중요한 정보를 제공합니다.

치료제 개발을 위한 제약회사의 R&D 아웃소싱이 증가함에 따라 단백질 결합 분석의 채택이 증가할 것으로 예상됩니다. 분자 연구 및 분석을 위해 이러한 서비스를 제공하는 여러 회사가 존재한다는 것은 예측 기간 동안 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

이러한 분석은 치료제 후보물질의 선택과 개발에 있어 ADME 특성을 이해하는 데 도움이 됩니다. 신약 개발 중 안전 마진을 추정하는 것은 새로운 화학제품의 단백질 결합을 정량화함으로써 수행될 수 있는 중요한 단계입니다.

단백질 결합 분석 시장 보고서 하이라이트

• 2023년 시장 점유율은 서비스 분야가 44.7%로 우세했습니다. 기술 발전, 전략적 투자, 소비자 수요 증가가 시장 성장을 견인할 것으로 예상됩니다.
• 평형 투석은 2023년 49.7%의 점유율로 우위를 차지했습니다. 과학자와 연구자들은 저렴한 가격과 높은 정확도로 이 기술을 선호합니다.
• 제약 및 생명공학 분야는 2023년 46.4%의 점유율을 차지했습니다. 광범위하고 강력한 유통망과 신약개발에 대한 막대한 투자 등의 요인이 이 부문의 성장을 견인하고 있습니다.
• 북미 단백질 결합 분석은 2023년 40.8%의 점유율로 세계 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 단백질 결합 분석 시장 변수, 동향, 범위

• 시장 소개/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 단백질 결합 분석 시장 분석 툴
  • Porters 분석
  • PESTEL 분석

제4장 단백질 결합 분석 시장 : 제품·서비스 추정·동향 분석

• 부문 대시보드
• 단백질 결합 분석 시장 : 제품·서비스 변동 분석, 2023년과 2030년
• 기기
• 키트와 시약
• 서비스

제5장 단백질 결합 분석 시장 : 기술 추정·동향 분석

• 부문 대시보드
• 단백질 결합 분석 시장 : 기술 변동 분석, 2023년 및 2030년
• 초원심분리
• 평형 투석
• 한외여과
• 표면 플라즈몬 공명
• 기타

제6장 단백질 결합 분석 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 단백질 결합 분석 시장 : 최종 용도 변동 분석, 2023년 및 2030년
• 수탁연구기관
• 제약·바이오테크놀러지 기업
• 기타

제7장 단백질 결합 분석 시장 : 지역 추정·동향 분석

• 단백질 결합 분석 시장 점유율, 지역별, 2023년 및 2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 스페인
  • 이탈리아
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트
  • 남아프리카공화국

제8장 경쟁 상황

• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • Thermo Fisher Scientific
  • ADMEcell, Inc
  • Beckman Coulter, Inc
  • Sartorius Stedim BioOutsource Limited
  • Bio-Rad Laboratories, Inc
  • Abzena Ltd
  • Abcam Plc
  • GVK Biosciences Private Limited
  • Promega Corporation
  • Arryait Corporation
  • Charles River Laboratories
  • Sovicell
  • Eurofins Scientific
  • 3B Pharmaceuticals
  • Creative Biolabs
  • Evotec SE
  • BioDuro-Sundia
  • Merck KGaA

ksm

영문 목차

영문목차

Protein Binding Assays Market Growth & Trends:

The global protein binding assays market size is expected to reach USD 896.3 million by 2030 at a CAGR of 10.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.

Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.

These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.

Protein Binding Assays Market Report Highlights:

• The services segment dominated with a market share of 44.7% in 2023. Technological advancements, strategic investments, and increasing consumer demand constitute market growth.
• The equilibrium dialysis dominated with a share of 49.7% in 2023. Scientists and researchers prefer this technique due to its low price and high accuracy.
• The pharmaceuticals and biotechnology segment dominated with a 46.4% market share in 2023. Factors such as a wide and strong distribution network and significant investments in drug discovery boost the segment growth.
• The North America protein binding assays dominated the global market with a share of 40.8% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Protein Binding Assay Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Protein Binding Assay Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining Power of the Suppliers
    • 3.4.1.2. Bargaining Power of the Buyers
    • 3.4.1.3. Threats of Substitution
    • 3.4.1.4. Threats From New Entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political Landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological Landscape
    • 3.4.2.4. Environmental Landscape
    • 3.4.2.5. Legal Landscape

Chapter 4. Protein Binding Assay Market: Product & Services Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Protein Binding Assay Market: Product & Services Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Instrument
  • 4.3.1. Instrument Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Kits & Reagents
  • 4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Protein Binding Assay Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Protein Binding Assay Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Ultracentrifugation
  • 5.3.1. Ultracentrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Equilibrium Dialysis
  • 5.4.1. Equilibrium Dialysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Ultrafiltration
  • 5.5.1. Ultrafiltration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Surface Plasmon Resonance
  • 5.6.1. Surface Plasmon Resonance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Protein Binding Assay Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Protein Binding Assay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
• 6.3. Contract Research Organizations
  • 6.3.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Protein Binding Assay Market: Regional Estimates & Trend Analysis

• 7.1. Protein Binding Assay Market Share, By Region, 2023 & 2030 (USD Million)
• 7.2. North America
  • 7.2.1. North America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. U.S. Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Canada Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Mexico Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. UK Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Germany Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. France Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5. Spain
    • 7.3.5.1. Spain Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6. Italy
    • 7.3.6.1. Italy Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.7. Norway
    • 7.3.7.1. Norway Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.8. Denmark
    • 7.3.8.1. Denmark Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.9. Sweden
    • 7.3.9.1. Sweden Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. China
    • 7.4.2.1. China Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Japan
    • 7.4.3.1. Japan Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. India Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. South Korea Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Australia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Thailand Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Brazil Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Argentina Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Middle East and Africa
  • 7.6.1. Middle East and Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Saudi Arabia
    • 7.6.2.1. Saudi Arabia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. UAE
    • 7.6.3.1. UAE Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Kuwait
    • 7.6.4.1. Kuwait Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Africa
    • 7.6.5.1. South Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Heat Map Analysis
• 8.4. Company Profiles
  • 8.4.1. Thermo Fisher Scientific
    • 8.4.1.1. Participant's Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Recent Developments/ Strategic Initiatives
  • 8.4.2. ADMEcell, Inc
    • 8.4.2.1. Participant's Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Recent Developments/ Strategic Initiatives
  • 8.4.3. Beckman Coulter, Inc
    • 8.4.3.1. Participant's Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Recent Developments/ Strategic Initiatives
  • 8.4.4. Sartorius Stedim BioOutsource Limited
    • 8.4.4.1. Participant's Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Recent Developments/ Strategic Initiatives
  • 8.4.5. Bio-Rad Laboratories, Inc
    • 8.4.5.1. Participant's Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Recent Developments/ Strategic Initiatives
  • 8.4.6. Abzena Ltd
    • 8.4.6.1. Participant's Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Recent Developments/ Strategic Initiatives
  • 8.4.7. Abcam Plc
    • 8.4.7.1. Participant's Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Recent Developments/ Strategic Initiatives
  • 8.4.8. GVK Biosciences Private Limited
    • 8.4.8.1. Participant's Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Recent Developments/ Strategic Initiatives
  • 8.4.9. Promega Corporation
    • 8.4.9.1. Participant's Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Recent Developments/ Strategic Initiatives
  • 8.4.10. Arryait Corporation
    • 8.4.10.1. Participant's Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Recent Developments/ Strategic Initiatives
  • 8.4.11. Charles River Laboratories
    • 8.4.11.1. Participant's Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Recent Developments/ Strategic Initiatives
  • 8.4.12. Sovicell
    • 8.4.12.1. Participant's Overview
    • 8.4.12.2. Financial Performance
    • 8.4.12.3. Product Benchmarking
    • 8.4.12.4. Recent Developments/ Strategic Initiatives
  • 8.4.13. Eurofins Scientific
    • 8.4.13.1. Participant's Overview
    • 8.4.13.2. Financial Performance
    • 8.4.13.3. Product Benchmarking
    • 8.4.13.4. Recent Developments/ Strategic Initiatives
  • 8.4.14. 3B Pharmaceuticals
    • 8.4.14.1. Participant's Overview
    • 8.4.14.2. Financial Performance
    • 8.4.14.3. Product Benchmarking
    • 8.4.14.4. Recent Developments/ Strategic Initiatives
  • 8.4.15. Creative Biolabs
    • 8.4.15.1. Participant's Overview
    • 8.4.15.2. Financial Performance
    • 8.4.15.3. Product Benchmarking
    • 8.4.15.4. Recent Developments/ Strategic Initiatives
  • 8.4.16. Evotec SE
    • 8.4.16.1. Participant's Overview
    • 8.4.16.2. Financial Performance
    • 8.4.16.3. Product Benchmarking
    • 8.4.16.4. Recent Developments/ Strategic Initiatives
  • 8.4.17. BioDuro-Sundia
    • 8.4.17.1. Participant's Overview
    • 8.4.17.2. Financial Performance
    • 8.4.17.3. Product Benchmarking
    • 8.4.17.4. Recent Developments/ Strategic Initiatives
  • 8.4.18. Merck KGaA
    • 8.4.18.1. Participant's Overview
    • 8.4.18.2. Financial Performance
    • 8.4.18.3. Product Benchmarking
    • 8.4.18.4. Recent Developments/ Strategic Initiatives

관련자료